{"abstracts-retrieval-response": {"item": {"ait:process-info": {"ait:status": {"@state": "update", "@type": "core", "@stage": "S300"}, "ait:date-delivered": {"@day": "29", "@year": "2024", "@timestamp": "2024-10-29T21:26:28.000028-04:00", "@month": "10"}, "ait:date-sort": {"@day": "01", "@year": "2014", "@month": "11"}}, "xocs:meta": {"xocs:funding-list": {"@pui-match": "primary", "@has-funding-info": "1", "xocs:funding": {"xocs:funding-agency-matched-string": "Janssen-Cilag Thailand"}, "xocs:funding-addon-generated-timestamp": "2021-06-01T16:22:59.169Z", "xocs:funding-text": "Source of funding and other support: This study was sponsored by Janssen-Cilag Thailand.", "xocs:funding-addon-type": "http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/aggregated-refined"}}, "bibrecord": {"head": {"author-group": [{"affiliation": {"country": "Thailand", "postal-code": "10330", "@afid": "60028190", "@country": "tha", "city": "Bangkok", "organization": [{"$": "Department of Obstetrics and Gynecology"}, {"$": "Faculty of Medicine"}, {"$": "Chulalongkorn University"}], "affiliation-id": {"@afid": "60028190", "@dptid": "113356767"}, "@dptid": "113356767"}, "author": [{"ce:given-name": "Unnop", "preferred-name": {"ce:given-name": "Unnop", "ce:initials": "U.", "ce:surname": "Jaisamrarn", "ce:indexed-name": "Jaisamrarn U."}, "@seq": "1", "ce:initials": "U.", "@_fa": "true", "@type": "auth", "ce:surname": "Jaisamrarn", "@auid": "6601992756", "ce:indexed-name": "Jaisamrarn U."}]}, {"affiliation": {"country": "Thailand", "@afid": "60032250", "@country": "tha", "city": "Chiang Mai", "organization": [{"$": "Department of Obstetrics and Gynecology"}, {"$": "Faculty of Medicine"}, {"$": "Chiang Mai University"}], "affiliation-id": [{"@afid": "60032250", "@dptid": "105345197"}, {"@afid": "60000881"}], "@dptid": "105345197"}, "author": [{"ce:given-name": "Somsak", "preferred-name": {"ce:given-name": "Somsak", "ce:initials": "S.", "ce:surname": "Chaovisitsaree", "ce:indexed-name": "Chaovisitsaree S."}, "@seq": "2", "ce:initials": "S.", "@_fa": "true", "@type": "auth", "ce:surname": "Chaovisitsaree", "@auid": "6507274562", "ce:indexed-name": "Chaovisitsaree S."}]}, {"affiliation": {"country": "Thailand", "@afid": "60199575", "@country": "tha", "city": "Bangkok", "organization": [{"$": "Department of Obstetrics and Gynecology"}, {"$": "Siriraj Hospital"}, {"$": "Mahidol University"}], "affiliation-id": [{"@afid": "60199575", "@dptid": "125771063"}, {"@afid": "60012718"}], "@dptid": "125771063"}, "author": [{"ce:given-name": "Surasak", "preferred-name": {"ce:given-name": "Surasak", "ce:initials": "S.", "ce:surname": "Angsuwathana", "ce:indexed-name": "Angsuwathana S."}, "@seq": "3", "ce:initials": "S.", "@_fa": "true", "@type": "auth", "ce:surname": "Angsuwathana", "@auid": "8222163200", "ce:indexed-name": "Angsuwathana S."}]}, {"affiliation": {"country": "Thailand", "@afid": "106946209", "@country": "tha", "city": "Bangkok", "organization": [{"$": "Medical Affairs"}, {"$": "Janssen-Cilag"}], "affiliation-id": {"@afid": "106946209"}}, "author": [{"ce:given-name": "Osot", "preferred-name": {"ce:given-name": "Osot", "ce:initials": "O.", "ce:surname": "Nerapusee", "ce:indexed-name": "Nerapusee O."}, "@seq": "4", "ce:initials": "O.", "@_fa": "true", "@type": "auth", "ce:surname": "Nerapusee", "@auid": "37024668000", "ce:indexed-name": "Nerapusee O."}]}], "citation-title": "A comparison of multiphasic oral contraceptives containing norgestimate or desogestrel in acne treatment: A randomized trial", "abstracts": "\u00a9 2014 Elsevier Inc. All rights reserved.Objective: This study aimed to compare the effectiveness and safety of triphasic combined oral contraceptives (OCs) containing ethinyl estradiol (EE) and norgestimate (NGM) and biphasic combined OCs containing EE and desogestrel (DSG) in the treatment of mild to moderate acne. Study design: This was an investigator-blinded, randomized, parallel group trial conducted at 3 centers in Thailand. Female subjects 18-45 years old were assigned to one or the other OCs and evaluated for efficacy and safety parameters at the baseline visit and after 1, 3 and 6 months of treatment. Results: Among 201 randomized subjects, data from 93 subjects in the EE/NGM group and 95 subjects in the EE/DSG group were analyzed. After 6 months of treatment with EE/NGM and EE/DSG, no differences between formulations were found for the decrease in total acne lesion counts (74.4% vs. 65.1%, respectively, p=.070) or facial improvement score. More women using EE/NGM showed a decrease in severity of facial seborrhea than those using EE/DSG (p=.005). No changes in weight were noted in either group as compared to baseline. Conclusion: Multiphasic OCs containing EE/NGM and EE/DSG provided comparable efficacy and tolerability in the treatment of acne. However, EE/NGM had a more beneficial effect on facial seborrhea reduction than EE/DSG. Implications: EE/NGM and EE/DSG are multiphasic OCs, which were shown to be clinically equally effective for mild to moderate facial acne, and the multiphasic combined OC with NGM was more effective for women with facial seborrhea. Clinicians may apply the results of this study when considering treatment options for facial acne and seborrhea.", "correspondence": {"affiliation": {"country": "Thailand", "postal-code": "10330", "@country": "tha", "city": "Bangkok", "organization": [{"$": "Department of Obstetrics and Gynecology"}, {"$": "Faculty of Medicine"}, {"$": "Chulalongkorn University"}]}, "person": {"ce:given-name": "Unnop", "ce:initials": "U.", "ce:surname": "Jaisamrarn", "ce:indexed-name": "Jaisamrarn U."}}, "citation-info": {"author-keywords": {"author-keyword": [{"$": "Acne lesion", "@xml:lang": "eng"}, {"$": "Biphasic oral contraceptive", "@xml:lang": "eng"}, {"$": "Facial seborrhea", "@xml:lang": "eng"}, {"$": "Triphasic oral contraceptive", "@xml:lang": "eng"}]}, "citation-type": {"@code": "ar"}, "citation-language": {"@language": "English", "@xml:lang": "eng"}, "abstract-language": {"@language": "English", "@xml:lang": "eng"}}, "source": {"website": {"ce:e-address": {"$": "www.elsevier.com/locate/contraception", "@type": "email"}}, "translated-sourcetitle": {"$": "Contraception", "@xml:lang": "eng"}, "volisspag": {"voliss": {"@volume": "90", "@issue": "5"}, "pagerange": {"@first": "535", "@last": "541"}}, "@type": "j", "sourcetitle": "Contraception", "publicationdate": {"month": "11", "year": "2014", "date-text": {"@xfab-added": "true", "$": "1 November 2014"}, "day": "01"}, "codencode": "CCPTA", "sourcetitle-abbrev": "Contraception", "@country": "usa", "issn": [{"$": "18790518", "@type": "electronic"}, {"$": "00107824", "@type": "print"}], "publicationyear": {"@first": "2014"}, "publisher": {"publishername": "Elsevier Inc."}, "@srcid": "24613"}, "enhancement": {"classificationgroup": {"classifications": [{"@type": "EMCLASS", "classification": [{"classification-code": "13", "classification-description": "Dermatology and Venereology"}, {"classification-code": "37", "classification-description": "Drug Literature Index"}, {"classification-code": "38", "classification-description": "Adverse Reactions Titles"}]}, {"@type": "ASJC", "classification": [{"$": "2743"}, {"$": "2729"}]}, {"@type": "SUBJABBR", "classification": "MEDI"}]}, "chemicalgroup": {"chemicals": [{"@source": "esbd", "chemical": [{"cas-registry-number": "54024-22-5", "chemical-name": "desogestrel"}, {"cas-registry-number": "57-63-6", "chemical-name": "ethinylestradiol"}, {"cas-registry-number": "35189-28-7", "chemical-name": "norgestimate"}, {"cas-registry-number": "6533-00-2", "chemical-name": "norgestrel"}]}, {"@source": "nlm", "chemical": [{"chemical-name": "Contraceptives, Oral, Synthetic"}, {"chemical-name": "Desogestrel"}, {"chemical-name": "norgestimate"}, {"chemical-name": "Norgestrel"}]}]}}}, "item-info": {"copyright": {"$": "Copyright 2021 Elsevier B.V., All rights reserved.", "@type": "Elsevier"}, "external-source": "MEDLINE", "dbcollection": [{"$": "CABS"}, {"$": "EMBASE"}, {"$": "MEDL"}, {"$": "MOSYEA"}, {"$": "NURSNG"}, {"$": "REAXYSCAR"}, {"$": "SCOPUS"}, {"$": "Scopusbase"}], "history": {"date-created": {"@day": "27", "@year": "2021", "@timestamp": "BST 09:14:02", "@month": "09"}}, "itemidlist": {"itemid": [{"$": "53255600", "@idtype": "PUI"}, {"$": "2021389868", "@idtype": "CABS"}, {"$": "625297512", "@idtype": "CAR-ID"}, {"$": "2014784114", "@idtype": "EMBASE"}, {"$": "25074072", "@idtype": "MEDL"}, {"$": "2021209251", "@idtype": "MOSYEA"}, {"$": "2021423894", "@idtype": "NURSNG"}, {"$": "20213660841", "@idtype": "REAXYSCAR"}, {"$": "20143186055", "@idtype": "SCOPUS"}, {"$": "84923195602", "@idtype": "SCP"}, {"$": "84923195602", "@idtype": "SGR"}, {"$": "604826682", "@idtype": "PUIsecondary"}], "ce:pii": "S0010782414003023", "ce:doi": "10.1016/j.contraception.2014.06.002"}}, "tail": {"bibliography": {"@refcount": "21", "reference": [{"ref-fulltext": "Thiboutot D. New treatments and therapeutic strategies for acne. Arch Fam Med 2000;9:179-87.", "@id": "1", "ref-info": {"ref-publicationyear": {"@first": "2000"}, "ref-title": {"ref-titletext": "New treatments and therapeutic strategies for acne"}, "refd-itemidlist": {"itemid": {"$": "0033834908", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "9"}, "pagerange": {"@first": "179", "@last": "187"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Thiboutot", "ce:indexed-name": "Thiboutot D."}]}, "ref-sourcetitle": "Arch Fam Med"}}, {"ref-fulltext": "Harper JC. An update on the pathogenesis and management of acne vulgaris. J Am Acad Dermatol 2004;51:S36-8, http://dx.doi.org/10.1016/j.jaad.2004.01.023.", "@id": "2", "ref-info": {"ref-publicationyear": {"@first": "2004"}, "ref-website": {"ce:e-address": {"$": "http://dx.doi.org/10.1016/j.jaad.2004.01.023", "@type": "email"}}, "ref-title": {"ref-titletext": "An update on the pathogenesis and management of acne vulgaris"}, "refd-itemidlist": {"itemid": {"$": "3042812657", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "51"}, "pagerange": {"@first": "S36", "@last": "S38"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "J.C.", "@_fa": "true", "ce:surname": "Harper", "ce:indexed-name": "Harper J.C."}]}, "ref-sourcetitle": "J Am Acad Dermatol"}}, {"ref-fulltext": "Redmond GP. Effectiveness of oral contraceptives in the treatment of acne. Contraception 1998;58:29S-33S.", "@id": "3", "ref-info": {"ref-publicationyear": {"@first": "1998"}, "ref-title": {"ref-titletext": "Effectiveness of oral contraceptives in the treatment of acne"}, "refd-itemidlist": {"itemid": {"$": "0031769283", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "58"}, "pagerange": {"@first": "29S", "@last": "33S"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "G.P.", "@_fa": "true", "ce:surname": "Redmond", "ce:indexed-name": "Redmond G.P."}]}, "ref-sourcetitle": "Contraception"}}, {"ref-fulltext": "Salvaggio HL, Zaenglein AL. Examining the use of oral contraceptives in the management of acne. Int J Womens Health 2010;2:69-76.", "@id": "4", "ref-info": {"ref-publicationyear": {"@first": "2010"}, "ref-title": {"ref-titletext": "Examining the use of oral contraceptives in the management of acne"}, "refd-itemidlist": {"itemid": {"$": "77953421042", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "2"}, "pagerange": {"@first": "69", "@last": "76"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "H.L.", "@_fa": "true", "ce:surname": "Salvaggio", "ce:indexed-name": "Salvaggio H.L."}, {"@seq": "2", "ce:initials": "A.L.", "@_fa": "true", "ce:surname": "Zaenglein", "ce:indexed-name": "Zaenglein A.L."}]}, "ref-sourcetitle": "Int J Womens Health"}}, {"ref-fulltext": "Schindler AE, Campagnoli C, Druckmann R, et al. Classification and pharmacology of progestins. Maturitas 2008;61:171-80.", "@id": "5", "ref-info": {"ref-publicationyear": {"@first": "2008"}, "ref-title": {"ref-titletext": "Classification and pharmacology of progestins"}, "refd-itemidlist": {"itemid": {"$": "72749125225", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "61"}, "pagerange": {"@first": "171", "@last": "180"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "A.E.", "@_fa": "true", "ce:surname": "Schindler", "ce:indexed-name": "Schindler A.E."}, {"@seq": "2", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Campagnoli", "ce:indexed-name": "Campagnoli C."}, {"@seq": "3", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Druckmann", "ce:indexed-name": "Druckmann R."}], "et-al": null}, "ref-sourcetitle": "Maturitas"}}, {"ref-fulltext": "Upton GV. The phasic approach to oral contraception: the triphasic concept and its clinical application. Int J Fertil 1983;28:121-40.", "@id": "6", "ref-info": {"ref-publicationyear": {"@first": "1983"}, "ref-title": {"ref-titletext": "The phasic approach to oral contraception: The triphasic concept and its clinical application"}, "refd-itemidlist": {"itemid": {"$": "0021063962", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "28"}, "pagerange": {"@first": "121", "@last": "140"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "G.V.", "@_fa": "true", "ce:surname": "Upton", "ce:indexed-name": "Upton G.V."}]}, "ref-sourcetitle": "Int J Fertil"}}, {"ref-fulltext": "London RS, Chapdelaine A, Upmalis D, Olson W, Smith J. Comparative contraceptive efficacy and mechanism of action of the norgestimate-containing triphasic oral contraceptive. Acta Obstet Gynecol Scand Suppl 1992;71(Suppl 156):9-4.", "@id": "7", "ref-info": {"ref-publicationyear": {"@first": "1992"}, "ref-title": {"ref-titletext": "Comparative contraceptive efficacy and mechanism of action of the norgestimate-containing triphasic oral contraceptive"}, "refd-itemidlist": {"itemid": {"$": "0026803177", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "71"}, "pagerange": {"@first": "9", "@last": "14"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "R.S.", "@_fa": "true", "ce:surname": "London", "ce:indexed-name": "London R.S."}, {"@seq": "2", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Chapdelaine", "ce:indexed-name": "Chapdelaine A."}, {"@seq": "3", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Upmalis", "ce:indexed-name": "Upmalis D."}, {"@seq": "4", "ce:initials": "W.", "@_fa": "true", "ce:surname": "Olson", "ce:indexed-name": "Olson W."}, {"@seq": "5", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Smith", "ce:indexed-name": "Smith J."}]}, "ref-sourcetitle": "Acta Obstet Gynecol Scand Suppl"}}, {"ref-fulltext": "Corson SL. Efficacy and safety of a monophasic and a triphasic oral contraceptive containing norgestimate. Am J Obstet Gynecol 1994;170:1556-61.", "@id": "8", "ref-info": {"ref-publicationyear": {"@first": "1994"}, "ref-title": {"ref-titletext": "Efficacy and safety of a monophasic and a triphasic oral contraceptive containing norgestimate"}, "refd-itemidlist": {"itemid": {"$": "0028290072", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "170"}, "pagerange": {"@first": "1556", "@last": "1561"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "S.L.", "@_fa": "true", "ce:surname": "Corson", "ce:indexed-name": "Corson S.L."}]}, "ref-sourcetitle": "Am J Obstet Gynecol"}}, {"ref-fulltext": "Phillips A, Demarest K, Hahn DW, Wong F, McGuire JL. Progestational and androgenic receptor binding affinities and in vivo activities of norgestimate and other progestins. Contraception 1990;41:399-410.", "@id": "9", "ref-info": {"ref-publicationyear": {"@first": "1990"}, "ref-title": {"ref-titletext": "Progestational and androgenic receptor binding affinities and in vivo activities of norgestimate and other progestins"}, "refd-itemidlist": {"itemid": {"$": "0025230237", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "41"}, "pagerange": {"@first": "399", "@last": "410"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Phillips", "ce:indexed-name": "Phillips A."}, {"@seq": "2", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Demarest", "ce:indexed-name": "Demarest K."}, {"@seq": "3", "ce:initials": "D.W.", "@_fa": "true", "ce:surname": "Hahn", "ce:indexed-name": "Hahn D.W."}, {"@seq": "4", "ce:initials": "F.", "@_fa": "true", "ce:surname": "Wong", "ce:indexed-name": "Wong F."}, {"@seq": "5", "ce:initials": "J.L.", "@_fa": "true", "ce:surname": "McGuire", "ce:indexed-name": "McGuire J.L."}]}, "ref-sourcetitle": "Contraception"}}, {"ref-fulltext": "Redmond GP, Olson WH, Lippman JS, Kafrissen ME, Jones TM, Jorizzo JL. Norgestimate and ethinyl estradiol in the treatment of acne vulgaris: a randomized, placebo-controlled trial. Obstet Gynecol 1997;89:615-22.", "@id": "10", "ref-info": {"ref-publicationyear": {"@first": "1997"}, "ref-title": {"ref-titletext": "Norgestimate and ethinyl estradiol in the treatment of acne vulgaris: A randomized, placebo-controlled trial"}, "refd-itemidlist": {"itemid": {"$": "0031127746", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "89"}, "pagerange": {"@first": "615", "@last": "622"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "G.P.", "@_fa": "true", "ce:surname": "Redmond", "ce:indexed-name": "Redmond G.P."}, {"@seq": "2", "ce:initials": "W.H.", "@_fa": "true", "ce:surname": "Olson", "ce:indexed-name": "Olson W.H."}, {"@seq": "3", "ce:initials": "J.S.", "@_fa": "true", "ce:surname": "Lippman", "ce:indexed-name": "Lippman J.S."}, {"@seq": "4", "ce:initials": "M.E.", "@_fa": "true", "ce:surname": "Kafrissen", "ce:indexed-name": "Kafrissen M.E."}, {"@seq": "5", "ce:initials": "T.M.", "@_fa": "true", "ce:surname": "Jones", "ce:indexed-name": "Jones T.M."}, {"@seq": "6", "ce:initials": "J.L.", "@_fa": "true", "ce:surname": "Jorizzo", "ce:indexed-name": "Jorizzo J.L."}]}, "ref-sourcetitle": "Obstet Gynecol"}}, {"ref-fulltext": "Lucky AW, Henderson TA, Olson WH, Robisch DM, Lebwohl M, Swinyer LJ. Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris. J Am Acad Dermatol 1997;37:746-54.", "@id": "11", "ref-info": {"ref-publicationyear": {"@first": "1997"}, "ref-title": {"ref-titletext": "Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris"}, "refd-itemidlist": {"itemid": {"$": "0030693350", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "37"}, "pagerange": {"@first": "746", "@last": "754"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "A.W.", "@_fa": "true", "ce:surname": "Lucky", "ce:indexed-name": "Lucky A.W."}, {"@seq": "2", "ce:initials": "T.A.", "@_fa": "true", "ce:surname": "Henderson", "ce:indexed-name": "Henderson T.A."}, {"@seq": "3", "ce:initials": "W.H.", "@_fa": "true", "ce:surname": "Olson", "ce:indexed-name": "Olson W.H."}, {"@seq": "4", "ce:initials": "D.M.", "@_fa": "true", "ce:surname": "Robisch", "ce:indexed-name": "Robisch D.M."}, {"@seq": "5", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Lebwohl", "ce:indexed-name": "Lebwohl M."}, {"@seq": "6", "ce:initials": "L.J.", "@_fa": "true", "ce:surname": "Swinyer", "ce:indexed-name": "Swinyer L.J."}]}, "ref-sourcetitle": "J Am Acad Dermatol"}}, {"ref-fulltext": "Kloosterboer HJ, Vonk-Noordegraaf CA, Turpijn EW. Selectivity in progesterone and androgen receptor binding of progestagens used in oral contraceptives. Contraception 1988;38:325-32.", "@id": "12", "ref-info": {"ref-publicationyear": {"@first": "1988"}, "ref-title": {"ref-titletext": "Selectivity in progesterone and androgen receptor binding of progestagens used in oral contraceptives"}, "refd-itemidlist": {"itemid": {"$": "0023802958", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "38"}, "pagerange": {"@first": "325", "@last": "332"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "H.J.", "@_fa": "true", "ce:surname": "Kloosterboer", "ce:indexed-name": "Kloosterboer H.J."}, {"@seq": "2", "ce:initials": "C.A.", "@_fa": "true", "ce:surname": "Vonk-Noordegraaf", "ce:indexed-name": "Vonk-Noordegraaf C.A."}, {"@seq": "3", "ce:initials": "E.W.", "@_fa": "true", "ce:surname": "Turpijn", "ce:indexed-name": "Turpijn E.W."}]}, "ref-sourcetitle": "Contraception"}}, {"ref-fulltext": "Jung-Hoffmann C, Storch A, Kuhl H. Serum concentrations of ethinylestradiol, 3-keto-desogestrel, SHBG, CBG and gonadotropins during treatment with a biphasic oral contraceptive containing desogestrel. Horm Res 1992;38:184-9.", "@id": "13", "ref-info": {"ref-publicationyear": {"@first": "1992"}, "ref-title": {"ref-titletext": "Serum concentrations of ethinylestradiol, 3-keto-desogestrel, SHBG, CBG and gonadotropins during treatment with a biphasic oral contraceptive containing desogestrel"}, "refd-itemidlist": {"itemid": {"$": "0026987502", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "38"}, "pagerange": {"@first": "184", "@last": "189"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Jung-Hoffmann", "ce:indexed-name": "Jung-Hoffmann C."}, {"@seq": "2", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Storch", "ce:indexed-name": "Storch A."}, {"@seq": "3", "ce:initials": "H.", "@_fa": "true", "ce:surname": "Kuhl", "ce:indexed-name": "Kuhl H."}]}, "ref-sourcetitle": "Horm Res"}}, {"ref-fulltext": "Falsetti L. Acne treatment with a new estroprogestinic biphasic combination containing desogestrel. Acta Eur Fertil 1991;22:283-6.", "@id": "14", "ref-info": {"ref-publicationyear": {"@first": "1991"}, "ref-title": {"ref-titletext": "Acne treatment with a new estroprogestinic biphasic combination containing desogestrel"}, "refd-itemidlist": {"itemid": {"$": "0026366233", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "22"}, "pagerange": {"@first": "283", "@last": "286"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "L.", "@_fa": "true", "ce:surname": "Falsetti", "ce:indexed-name": "Falsetti L."}]}, "ref-sourcetitle": "Acta Eur Fertil"}}, {"ref-fulltext": "O'Brien S, Lewis J, Cunliffe W. The Leeds revised acne grading system. J Dermatol Treat 1998;9:215-20.", "@id": "15", "ref-info": {"ref-publicationyear": {"@first": "1998"}, "ref-title": {"ref-titletext": "The Leeds revised acne grading system"}, "refd-itemidlist": {"itemid": {"$": "0032439571", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "9"}, "pagerange": {"@first": "215", "@last": "220"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "S.", "@_fa": "true", "ce:surname": "O'Brien", "ce:indexed-name": "O'Brien S."}, {"@seq": "2", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Lewis", "ce:indexed-name": "Lewis J."}, {"@seq": "3", "ce:initials": "W.", "@_fa": "true", "ce:surname": "Cunliffe", "ce:indexed-name": "Cunliffe W."}]}, "ref-sourcetitle": "J Dermatol Treat"}}, {"ref-fulltext": "Vartiainen M, de Gezelle H, Broekmeulen CJ. Comparison of the effect on acne with a combiphasic desogestrel-containing oral contraceptive and a preparation containing cyproterone acetate. Eur J Contracept Reprod Health Care 2001;6:46-53.", "@id": "16", "ref-info": {"ref-publicationyear": {"@first": "2001"}, "ref-title": {"ref-titletext": "Comparison of the effect on acne with a combiphasic desogestrel-containing oral contraceptive and a preparation containing cyproterone acetate"}, "refd-itemidlist": {"itemid": {"$": "0035031770", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "6"}, "pagerange": {"@first": "46", "@last": "53"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Vartiainen", "ce:indexed-name": "Vartiainen M."}, {"@seq": "2", "ce:initials": "H.", "@_fa": "true", "ce:surname": "De Gezelle", "ce:indexed-name": "De Gezelle H."}, {"@seq": "3", "ce:initials": "C.J.", "@_fa": "true", "ce:surname": "Broekmeulen", "ce:indexed-name": "Broekmeulen C.J."}]}, "ref-sourcetitle": "Eur J Contracept Reprod Health Care"}}, {"ref-fulltext": "Kr\u00e4nzlin HT, Nap MA. The effect of a phasic oral contraceptive containing desogestrel on seborrhea and acne. Eur J Contracept Reprod Health Care 2006;11:6-3.", "@id": "17", "ref-info": {"ref-publicationyear": {"@first": "2006"}, "ref-title": {"ref-titletext": "The effect of a phasic oral contraceptive containing desogestrel on seborrhea and acne"}, "refd-itemidlist": {"itemid": {"$": "33645275204", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "11"}, "pagerange": {"@first": "6", "@last": "13"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "H.T.", "@_fa": "true", "ce:surname": "Kr\u00e4nzlin", "ce:indexed-name": "Kranzlin H.T."}, {"@seq": "2", "ce:initials": "M.A.", "@_fa": "true", "ce:surname": "Nap", "ce:indexed-name": "Nap M.A."}]}, "ref-sourcetitle": "Eur J Contracept Reprod Health Care"}}, {"ref-fulltext": "Lello S, Primavera G, Colonna L, et al. Effects of two estroprogestins containing ethynilestradiol 30 microg and drospirenone 3mg and ethynilestradiol 30 microg and chlormadinone 2mg on skin and hormonal hyperandrogenic manifestations. Gynecol Endocrinol 2008;24:718-23.", "@id": "18", "ref-info": {"ref-publicationyear": {"@first": "2008"}, "ref-title": {"ref-titletext": "Effects of two estroprogestins containing ethynilestradiol 30 microg and drospirenone 3mg and ethynilestradiol 30 microg and chlormadinone 2mg on skin and hormonal hyperandrogenic manifestations"}, "refd-itemidlist": {"itemid": {"$": "64349093259", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "24"}, "pagerange": {"@first": "718", "@last": "723"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Lello", "ce:indexed-name": "Lello S."}, {"@seq": "2", "ce:initials": "G.", "@_fa": "true", "ce:surname": "Primavera", "ce:indexed-name": "Primavera G."}, {"@seq": "3", "ce:initials": "L.", "@_fa": "true", "ce:surname": "Colonna", "ce:indexed-name": "Colonna L."}], "et-al": null}, "ref-sourcetitle": "Gynecol Endocrinol"}}, {"ref-fulltext": "Brucker C, Hedon B, The HS, H\u00f6schen K, Binder N, Christoph A. Long-term efficacy and safety of a monophasic combined oral contraceptive containing 0.02mg ethinylestradiol and 2mg chlormadinone acetate administered in a 24/4-day regimen. Contraception 2010;81:501-9.", "@id": "19", "ref-info": {"ref-publicationyear": {"@first": "2010"}, "ref-title": {"ref-titletext": "Long-term efficacy and safety of a monophasic combined oral contraceptive containing 0.02mg ethinylestradiol and 2mg chlormadinone acetate administered in a 24/4-day regimen"}, "refd-itemidlist": {"itemid": {"$": "77952110038", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "81"}, "pagerange": {"@first": "501", "@last": "509"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Brucker", "ce:indexed-name": "Brucker C."}, {"@seq": "2", "ce:initials": "B.", "@_fa": "true", "ce:surname": "Hedon", "ce:indexed-name": "Hedon B."}, {"@seq": "3", "ce:initials": "H.S.", "@_fa": "true", "ce:surname": "The", "ce:indexed-name": "The H.S."}, {"@seq": "4", "ce:initials": "K.", "@_fa": "true", "ce:surname": "H\u00f6schen", "ce:indexed-name": "Hoschen K."}, {"@seq": "5", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Binder", "ce:indexed-name": "Binder N."}, {"@seq": "6", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Christoph", "ce:indexed-name": "Christoph A."}]}, "ref-sourcetitle": "Contraception"}}, {"ref-fulltext": "Plewig G, Cunliffe WJ, Binder N, H\u00f6schen K. Efficacy of an oral contraceptive containing EE 0.03mg and CMA 2mg (Belara\u00ae) in moderate acne resolution: a randomized, double-blind, placebo-controlled Phase III trial. Contraception 2009;80:25-33.", "@id": "20", "ref-info": {"ref-publicationyear": {"@first": "2009"}, "ref-title": {"ref-titletext": "Efficacy of an oral contraceptive containing EE 0.03mg and CMA 2mg (Belara\u00ae) in moderate acne resolution: A randomized, double-blind, placebo-controlled Phase III trial"}, "refd-itemidlist": {"itemid": {"$": "67349136077", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "80"}, "pagerange": {"@first": "25", "@last": "33"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "G.", "@_fa": "true", "ce:surname": "Plewig", "ce:indexed-name": "Plewig G."}, {"@seq": "2", "ce:initials": "W.J.", "@_fa": "true", "ce:surname": "Cunliffe", "ce:indexed-name": "Cunliffe W.J."}, {"@seq": "3", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Binder", "ce:indexed-name": "Binder N."}, {"@seq": "4", "ce:initials": "K.", "@_fa": "true", "ce:surname": "H\u00f6schen", "ce:indexed-name": "Hoschen K."}]}, "ref-sourcetitle": "Contraception"}}, {"ref-fulltext": "Rosenberg MJ, Waugh MS. Oral contraceptive discontinuation: a prospective evaluation of frequency and reasons. Am J Obstet Gynecol 1998;179:577-82.", "@id": "21", "ref-info": {"ref-publicationyear": {"@first": "1998"}, "ref-title": {"ref-titletext": "Oral contraceptive discontinuation: A prospective evaluation of frequency and reasons"}, "refd-itemidlist": {"itemid": {"$": "0031712077", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "179"}, "pagerange": {"@first": "577", "@last": "582"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.J.", "@_fa": "true", "ce:surname": "Rosenberg", "ce:indexed-name": "Rosenberg M.J."}, {"@seq": "2", "ce:initials": "M.S.", "@_fa": "true", "ce:surname": "Waugh", "ce:indexed-name": "Waugh M.S."}]}, "ref-sourcetitle": "Am J Obstet Gynecol"}}]}}}}, "affiliation": [{"affiliation-city": "Bangkok", "@id": "60199575", "affilname": "Siriraj Hospital", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199575", "affiliation-country": "Thailand"}, {"affiliation-city": "Chiang Mai", "@id": "60032250", "affilname": "Faculty of Medicine, Chiang Mai University", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60032250", "affiliation-country": "Thailand"}, {"affiliation-city": "Bangkok", "@id": "60028190", "affilname": "Chulalongkorn University", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190", "affiliation-country": "Thailand"}, {"affiliation-city": "Bangkok", "@id": "106946209", "affilname": "Janssen-Cilag", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/106946209", "affiliation-country": "Thailand"}], "coredata": {"srctype": "j", "eid": "2-s2.0-84923195602", "dc:description": "Objective: This study aimed to compare the effectiveness and safety of triphasic combined oral contraceptives (OCs) containing ethinyl estradiol (EE) and norgestimate (NGM) and biphasic combined OCs containing EE and desogestrel (DSG) in the treatment of mild to moderate acne. Study design: This was an investigator-blinded, randomized, parallel group trial conducted at 3 centers in Thailand. Female subjects 18-45 years old were assigned to one or the other OCs and evaluated for efficacy and safety parameters at the baseline visit and after 1, 3 and 6 months of treatment. Results: Among 201 randomized subjects, data from 93 subjects in the EE/NGM group and 95 subjects in the EE/DSG group were analyzed. After 6 months of treatment with EE/NGM and EE/DSG, no differences between formulations were found for the decrease in total acne lesion counts (74.4% vs. 65.1%, respectively, p=.070) or facial improvement score. More women using EE/NGM showed a decrease in severity of facial seborrhea than those using EE/DSG (p=.005). No changes in weight were noted in either group as compared to baseline. Conclusion: Multiphasic OCs containing EE/NGM and EE/DSG provided comparable efficacy and tolerability in the treatment of acne. However, EE/NGM had a more beneficial effect on facial seborrhea reduction than EE/DSG. Implications: EE/NGM and EE/DSG are multiphasic OCs, which were shown to be clinically equally effective for mild to moderate facial acne, and the multiphasic combined OC with NGM was more effective for women with facial seborrhea. Clinicians may apply the results of this study when considering treatment options for facial acne and seborrhea.", "pubmed-id": "25074072", "prism:coverDate": "2014-11-01", "prism:aggregationType": "Journal", "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/84923195602", "dc:creator": {"author": [{"ce:given-name": "Unnop", "preferred-name": {"ce:given-name": "Unnop", "ce:initials": "U.", "ce:surname": "Jaisamrarn", "ce:indexed-name": "Jaisamrarn U."}, "@seq": "1", "ce:initials": "U.", "@_fa": "true", "affiliation": {"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}, "ce:surname": "Jaisamrarn", "@auid": "6601992756", "author-url": "https://api.elsevier.com/content/author/author_id/6601992756", "ce:indexed-name": "Jaisamrarn U."}]}, "link": [{"@_fa": "true", "@rel": "self", "@href": "https://api.elsevier.com/content/abstract/scopus_id/84923195602"}, {"@_fa": "true", "@rel": "scopus", "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84923195602&origin=inward"}, {"@_fa": "true", "@rel": "scopus-citedby", "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=84923195602&origin=inward"}], "source-id": "24613", "pii": "S0010782414003023", "citedby-count": "19", "prism:volume": "90", "subtype": "ar", "dc:title": "A comparison of multiphasic oral contraceptives containing norgestimate or desogestrel in acne treatment: A randomized trial", "openaccess": "0", "prism:issn": "18790518 00107824", "publishercopyright": "\u00a9 2014 Elsevier Inc. All rights reserved.", "prism:issueIdentifier": "5", "subtypeDescription": "Article", "prism:publicationName": "Contraception", "prism:pageRange": "535-541", "prism:endingPage": "541", "openaccessFlag": "false", "prism:doi": "10.1016/j.contraception.2014.06.002", "prism:startingPage": "535", "dc:identifier": "SCOPUS_ID:84923195602", "dc:publisher": "Elsevier Inc."}, "idxterms": {"mainterm": [{"$": "Acne Vulgaris", "@weight": "b", "@candidate": "n"}, {"$": "Adult", "@weight": "b", "@candidate": "n"}, {"$": "Contraceptives, Oral, Synthetic", "@weight": "b", "@candidate": "n"}, {"$": "Desogestrel", "@weight": "b", "@candidate": "n"}, {"$": "Female", "@weight": "b", "@candidate": "n"}, {"$": "Humans", "@weight": "b", "@candidate": "n"}, {"$": "Norgestrel", "@weight": "b", "@candidate": "n"}, {"$": "Treatment Outcome", "@weight": "b", "@candidate": "n"}, {"$": "Young Adult", "@weight": "b", "@candidate": "n"}]}, "language": {"@xml:lang": "eng"}, "authkeywords": {"author-keyword": [{"@_fa": "true", "$": "Acne lesion"}, {"@_fa": "true", "$": "Biphasic oral contraceptive"}, {"@_fa": "true", "$": "Facial seborrhea"}, {"@_fa": "true", "$": "Triphasic oral contraceptive"}]}, "subject-areas": {"subject-area": [{"@_fa": "true", "$": "Reproductive Medicine", "@code": "2743", "@abbrev": "MEDI"}, {"@_fa": "true", "$": "Obstetrics and Gynecology", "@code": "2729", "@abbrev": "MEDI"}]}, "authors": {"author": [{"ce:given-name": "Unnop", "preferred-name": {"ce:given-name": "Unnop", "ce:initials": "U.", "ce:surname": "Jaisamrarn", "ce:indexed-name": "Jaisamrarn U."}, "@seq": "1", "ce:initials": "U.", "@_fa": "true", "affiliation": {"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}, "ce:surname": "Jaisamrarn", "@auid": "6601992756", "author-url": "https://api.elsevier.com/content/author/author_id/6601992756", "ce:indexed-name": "Jaisamrarn U."}, {"ce:given-name": "Somsak", "preferred-name": {"ce:given-name": "Somsak", "ce:initials": "S.", "ce:surname": "Chaovisitsaree", "ce:indexed-name": "Chaovisitsaree S."}, "@seq": "2", "ce:initials": "S.", "@_fa": "true", "affiliation": {"@id": "60032250", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60032250"}, "ce:surname": "Chaovisitsaree", "@auid": "6507274562", "author-url": "https://api.elsevier.com/content/author/author_id/6507274562", "ce:indexed-name": "Chaovisitsaree S."}, {"ce:given-name": "Surasak", "preferred-name": {"ce:given-name": "Surasak", "ce:initials": "S.", "ce:surname": "Angsuwathana", "ce:indexed-name": "Angsuwathana S."}, "@seq": "3", "ce:initials": "S.", "@_fa": "true", "affiliation": {"@id": "60199575", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199575"}, "ce:surname": "Angsuwathana", "@auid": "8222163200", "author-url": "https://api.elsevier.com/content/author/author_id/8222163200", "ce:indexed-name": "Angsuwathana S."}, {"ce:given-name": "Osot", "preferred-name": {"ce:given-name": "Osot", "ce:initials": "O.", "ce:surname": "Nerapusee", "ce:indexed-name": "Nerapusee O."}, "@seq": "4", "ce:initials": "O.", "@_fa": "true", "affiliation": {"@id": "106946209", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/106946209"}, "ce:surname": "Nerapusee", "@auid": "37024668000", "author-url": "https://api.elsevier.com/content/author/author_id/37024668000", "ce:indexed-name": "Nerapusee O."}]}}}